Rachel Stahler
Chief Tech/Sci/R&D Officer presso ORGANON & CO.
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Rachel A. Stahler è nel consiglio di NeoGenomics, Inc. e NeoGenomics Laboratories, Inc. In passato ha occupato la posizione di Chief Information Officer di inVentiv Health Clinical, Inc., Chief Information Officer di Optimer Pharmaceuticals LLC, Chief Information Officer di inVentiv Health, Inc. e Chief Information Officer di InVentiv Group Holdings, Inc. Ha ricevuto un MBA da The Trustees of Columbia University a The City of New York e una laurea presso l'Università della Pennsylvania.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ORGANON & CO.
0.02% | 31/03/2024 | 46 233 ( 0.02% ) | 869 180 $ | 31/03/2024 |
NEOGENOMICS, INC.
0.02% | 27/03/2023 | 21 335 ( 0.02% ) | 335 386 $ | 31/03/2024 |
Posizioni attive di Rachel Stahler
Società | Posizione | Inizio |
---|---|---|
ORGANON & CO. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Director/Board Member | - |
Precedenti posizioni note di Rachel Stahler
Società | Posizione | Fine |
---|---|---|
NEOGENOMICS, INC. | Director/Board Member | 26/06/2023 |
ALLERGAN PLC | Chief Investment Officer | 01/01/2020 |
inVentiv Health, Inc.
inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
Ventiv Health, Inc. | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Formazione di Rachel Stahler
The Trustees of Columbia University in The City of New York | Masters Business Admin |
University of Pennsylvania | Undergraduate Degree |
Columbia University College of Physicians & Surgeons | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
NEOGENOMICS, INC. | Health Services |
ORGANON & CO. | Health Technology |
Aziende private | 9 |
---|---|
Ventiv Health, Inc. | Commercial Services |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Commercial Services |
Syneos Health NC LLC
Syneos Health NC LLC Miscellaneous Commercial ServicesCommercial Services Syneos Health LLC operates therapeutically focused global contract research organization. It provides pharma and biotech services. The firm specializes in the hematology, immunology and inflammation infectious diseases, oncology, ophthalmology, cardiovascular, CNS analgesia, CNS neurology, CNS psychiatry, endocrinology, and gastroenterology and hepatology. The company was founded by Kenneth A. Selzer in 1985 and is headquartered in Raleigh, NC. | Commercial Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
inVentiv Health, Inc.
inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Commercial Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
InVentiv Group Holdings, Inc.
InVentiv Group Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services InVentiv Group Holdings, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through two reportable business segments: Clinical and Commercial. The Clinical Segment provides a full suite of services spanning Phases I-IV of clinical development. The Commercial Segment addresses the needs of clients in support of and following product approval and links clinical development to healthcare delivery. The company was founded in May 2010 and is headquartered in Burlington, MA. | Commercial Services |
Allergan USA, Inc.
Allergan USA, Inc. Pharmaceuticals: MajorHealth Technology Allergan USA, Inc. manufactures and supplies pharmaceutical products. The firm's brand portfolio delivers treatments that address the medical need in various therapeutic categories that include dermatology and aesthetics; central nervous system; eye care; women’s health and urology; gastroenterology; and cardiovascular disease and infectious disease. The company was founded in June 2005 and is headquartered in Madison, NJ. | Health Technology |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Health Services |
- Borsa valori
- Insiders
- Rachel Stahler